ef at rest after doxorubicin was significantly lower ( 41 +/- 6 % vs 49 +/- 8 % , p less than 0.02 ) in these 11 patients than in the 29 patients in whom the pretreatment ef response to exercise was normal , and in 4 of the 11 patients congestive heart failure developed .
C0013089
doxorubicin
C0018802
congestive heart failure